Iop
Magnetic Resonance Imaging
MegaPro Biomedical Co. Ltd.Phase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Magnetic Resonance Imaging cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
GADOPENTETATE DIMEGLUMINE National Taiwan University Hospital | Phase 4 | BB |
FCH National Taiwan University Hospital | Phase 4 | BB |
BAY86-4882 Bayer | Phase 3 | BB |
BAY86-4875 Bayer | Phase 3 | BB |
Gadobutrol Bayer | Phase 3 | BB |
View all 14 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →